SCHEMBL9987990

SCHEMBL9987990

Oc1ccc(-c2[c]cccc2O)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 6/20 0.42
ESR2 Q92731 5/20 0.42
ALOX5 P09917 1/20 0.41
MMP3 P08254 1/20 0.41
BCL2L1 Q07817 1/20 0.41
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
MAPT P10636 4/20 0.38
ALDH1A1 P00352 3/20 0.38
HPGD P15428 3/20 0.38
HSD17B10 Q99714 3/20 0.38
NPC1 O15118 3/20 0.38
NFKB1 P19838 3/20 0.38
RAB9A P51151 3/20 0.38
POLB P06746 2/20 0.38
KDM4E B2RXH2 2/20 0.38
CA12 O43570 2/20 0.38
GMNN O75496 2/20 0.38
CA2 P00918 2/20 0.38
LMNA P02545 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6607387 0.84 ALDH1A1 (0.46) ESR2ALOX5MMP3BCL2L1MEN1
SCHEMBL9988099 0.83 TRPA1 (0.37) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL9650164 0.83 NPC1 (0.35) ALOX5BCL2L1MEN1KMT2AMAPT
SCHEMBL16720201 0.83 ALOX5 (0.45) ALOX5MEN1KMT2AMAPTALDH1A1
SCHEMBL6056277 0.81 ABL1 (0.45) ESR1ESR2ALOX5MMP3BCL2L1
SCHEMBL16720369 0.80 MKNK1 (0.37) ALOX5MAPTALDH1A1HPGDHSD17B10
SCHEMBL16720178 0.79 QDPR (0.44) MAPTALDH1A1HPGDHSD17B10NPC1
SCHEMBL16719458 0.79 KIF11 (0.47) ALDH1A1HSD17B10NPC1RAB9APOLB
SCHEMBL16720079 0.79 HRH3 (0.45) CA12CA2CA4CA5ACA14
SCHEMBL16719654 0.79 KDM4E (0.47) ESR2MEN1KMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2397462-A2 Compounds, compositions and methods of treatment for heart failure Cytokinetics, Inc. (US) 2011-12-21 EP claimed
CN-101094844-A Chroman derivatives, medicaments and use in therapy NOVOGEN RES PTY LTD (AU) 2007-12-26 CN claimed
JP-52095620-A None JP disclosed
CN-116113414-A Combination therapy 梅制药公司 2023-05-12 CN disclosed
EP-3068758-A1 EBNA1 INHIBITORS AND THEIR METHOD OF USE The Wistar Institute Of Anatomy And Biology (US) 2016-09-21 EP disclosed
WO-2015073864-A1 EBNA1 INHIBITORS AND THEIR METHOD OF USE THE WISAR INSTITUTE OF ANATOMY AND BIOLOGY (US) 2015-05-21 WO disclosed
JP-S5295620-A BENZEL ALCOHOL DERIVATIVES TANABE SEIYAKU CO LTD 1977-08-11 JP disclosed